Expression of p53 protein in pterygium

European Journal of Ophthalmology

Volumn 8, Issue 3, 1998, Pages 157-161

  Onur, C ^a   Orhan, D ^b   Orhan, M ^a   Dizbay Sak, S ^a   Tulunay, O ^b   Irkec M ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

P53 protein; Pathogenesis; Pterygium; Tumor suppressor genes

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; RADIATION EXPOSURE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

EID: 0031720890     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219800800307     Document Type: Article

References (35)

1. Karai I, Horiguchi S. Pterygium in welders. Br J Ophthalmol 1984; 68: 347-9.
2. Moran DJ, Hollows FC. Pterygium and ultraviolet radiation. Br J Ophthalmol 1984; 68: 343.
3. Dhir SP, Detels R, Alexander ER. The role of environmental factors in cataract, pterygium and trachoma. Am J Ophthalmol 1967; 67: 128-35.
4. Davanger M, Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 1971; 229: 560-2.
5. Coroneo MT. Pterygium as an early indicator of ultraviolet insulation: A hypothesis. Br J Ophthalmol 1984; 77: 734-9.
6. Tseng SCG. Concept and application of limbal stem cells. Eye 1989; 3: 141-57.
7. Thoft RA, Friend J. The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci 1983; 24: 1442-3.
8. Kwok S, Coroneo MT. A model for pterygium formation. Cornea 1994; 13: 219-24
9. Chang F, Syrjanen S, Tervahauta A, Syrjanen K. Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer 1993; 68: 653-61.
10. Boyd J, Barrett C. Tumour suppressor genes: possible functions in the negative regulation of cell proliferation. Mol Carcinog 1990; 3: 325-9.
11. O'Donoghue JM, Kerin MJ, Gven HF. The role of tumour suppressor gene p53. Eur J Surg Oncol 1994; 20: 175-7.
12. Tobal K, Warren W, Cooper CS, McCartney A, Hungerford J, Lightman S. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 1992; 66: 900-4.
13. Brash DE, Rudolph JA, Simon JA et al. A role for sunlight in skin cancer. W induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10120-8.
14. Hall PA, McKee PH, Menage HP, Dover R, Lane DP. High levels of p53 protein in UV irradiated normal human skin. Oncogene 1993; 8: 203-7.
15. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumour antigen in non-transformed mouse cells. Mol Cell Biol 1984; 4: 1689-94.
16. Diller L, Kassel J, Nelson CE et al. p53 function as a cycle control protein in osteosarcom. Mol Cell Biol 1990; 10: 5772-81.
17. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tisty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild type p53. Cell 1992; 70: 923-35
18. Yanish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin 6. Nature 1991; 352: 345-7.
19. Lane DP. p53; guardian of the genome. Nature 1992; 358: 15-6.
20. Wyllie AH. Apoptosis. Br J Cancer 1993; 67: 205-8.
21. Levine AJ, Perry ME, Chang A et al. The 1993 Walter Hubert lecture: The role of the p53 tumour-suppressor gene in tumourigenesis. Br J Cancer 1994; 69: 409-16.
22. Culotta E, Koshland D. p53 sweeps through cancer research. Science 1993; 262: 1958-61.
23. Rotter V, Prococimer M. p53 and human malignancies. Adv Cancer Res 1991; 57: 257-72.
24. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.
25. Wynford-Thomas D. p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992; 166: 329-30.
26. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984; 98: 225-8.
27. Chandler JW, Cummings M, Gillette TE. Presence of Langerhans cells in central corneas of normal human infants. Invest Ophthalmol Vis Sci 1985; 26: 113-6.
28. Ray-Keil L, Chandler JW. Reduction in the incidence of rejection of heterotrophic murine corneal transplants by pretreatment with ultraviolet radiation. Transplantation 1986; 42: 403-6.
29. Applegate LA, Ley RT. DNA damage is involved in the induction of opacification and neovascularization of the cornea by ultraviolet radiation. Exp Eye Res 1991; 52: 493-7.
30. Hogan MJ, Alvarado J. Pterygium and pinguecula: electron microscopic study. Arch Ophthalmol 1967; 78: 174-86.
31. Austin P, Jacobiec FA, Iwamoto T. Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pingueculae. Ophthalmology 1983; 90: 96-109.
32. Cooper PN, Lee JA, Quinn AG et al. p53 protein expression in benign and malignant skin tumours. Br J Dermatol 1993; 128: 237-41.
33. Gusterson BA, Anbazhagan R, Warren W et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6: 1785-9.
34. Tan DTH, Lim ASM, Goh HS, Smith DR. Abnormal expression of the p53 tumour suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997; 123: 404-5.
35. Dushku N, Reid TW. p53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997; 16: 1179-92.